Report Detail
Global DTaP and Tdap Vaccines Market Professional Survey Report 2019
- RnM3742504 |
- 12 September, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free environment. The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) recommend all children should be routinely vaccinated for pertussis. According to WHO in 2015, about 86% of infants received three doses of diphtheria-tetanus-pertussis (DTP3) vaccine worldwide to protect them against infectious diseases. In 2015, procurement of DTwP vaccine through UNICEF had reached 5.8 million doses for 18 countries and territories out of which four countries such as Egypt, Morocco, Uzbekistan, and Zimbabwe accounted for more than 80% of UNICEF’s total procurement.
Factors such as high birth rate, increase in number of geriatric population, government initiatives, growth in adoption of pertussis vaccination, and government insurance and reimbursement scenario are projected to drive the pertussis vaccine market globally. According to WHO in 2015, 126 countries had reached at least 90% coverage of diphtheria-tetanus-pertussis vaccine. On the other hand, factors such as vaccine injuries and adverse event are expected to hinder the growth of the pertussis vaccine market globally. In the U.S. in 2015, there had been 7 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following pertussis vaccination, including three deaths and four serious injuries.
The pertussis vaccine market has been segmented by product type, vaccine type, age group, end-user, and geography. In terms of product type, the pertussis vaccine market is classified into DTaP vaccine and Tdap vaccine. The DTaP vaccine segment includes products such as Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel. The Tdap vaccine segment comprises products such as Boostrix and Adacel. In terms of vaccine type, the pertussis vaccine market is classified into whole-cell vaccine and acellular vaccine. The acellular vaccine segment is highly used owing to less side effect. The acellular vaccine is about 71%–85% effective, whereas whole-cell vaccine is about 78% effective. In terms of age group, the pertussis vaccine market is classified into adult and pediatric. In terms of end-user, the market is classified into hospitals, clinics, and vaccination centers. Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S, which drive the pertussis vaccine market. In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S. The North America market is followed by the Europe and Asia Pacific markets. Asia Pacific is expected to grow at a higher rate due to rapid population growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. These factors are expected to fuel the pertussis vaccine market. In the Asia Pacific region, Thailand accounts for 99% in pertussis vaccine coverage, followed by Japan and China with 98% and 97%, respectively. Developing countries such as Brazil, South Africa, and Mexico are estimated to create good opportunity for the pertussis vaccine market growth attributing to rise in number of government and private health care insurance coverage, increase in health care expenditure, and growth in awareness among people.
The global DTaP and Tdap Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on DTaP and Tdap Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall DTaP and Tdap Vaccines market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of DTaP and Tdap Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their DTaP and Tdap Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
DTaP
Td
Tdap
Segment by Application
Adult
Pediatric
Table of Contents
Executive Summary
1 Industry Overview of DTaP and Tdap Vaccines
- 1.1 Definition of DTaP and Tdap Vaccines
- 1.2 DTaP and Tdap Vaccines Segment by Type
- 1.2.1 Global DTaP and Tdap Vaccines Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 DTaP
- 1.2.3 Td
- 1.2.4 Tdap
- 1.3 DTaP and Tdap Vaccines Segment by Applications
- 1.3.1 Global DTaP and Tdap Vaccines Consumption Comparison by Applications (2014-2025)
- 1.3.2 Adult
- 1.3.3 Pediatric
- 1.4 Global DTaP and Tdap Vaccines Overall Market
- 1.4.1 Global DTaP and Tdap Vaccines Revenue (2014-2025)
- 1.4.2 Global DTaP and Tdap Vaccines Production (2014-2025)
- 1.4.3 North America DTaP and Tdap Vaccines Status and Prospect (2014-2025)
- 1.4.4 Europe DTaP and Tdap Vaccines Status and Prospect (2014-2025)
- 1.4.5 China DTaP and Tdap Vaccines Status and Prospect (2014-2025)
- 1.4.6 Japan DTaP and Tdap Vaccines Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia DTaP and Tdap Vaccines Status and Prospect (2014-2025)
- 1.4.8 India DTaP and Tdap Vaccines Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of DTaP and Tdap Vaccines
- 2.3 Manufacturing Process Analysis of DTaP and Tdap Vaccines
- 2.4 Industry Chain Structure of DTaP and Tdap Vaccines
3 Development and Manufacturing Plants Analysis of DTaP and Tdap Vaccines
- 3.1 Capacity and Commercial Production Date
- 3.2 Global DTaP and Tdap Vaccines Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of DTaP and Tdap Vaccines
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 DTaP and Tdap Vaccines Production and Capacity Analysis
- 4.2 DTaP and Tdap Vaccines Revenue Analysis
- 4.3 DTaP and Tdap Vaccines Price Analysis
- 4.4 Market Concentration Degree
5 DTaP and Tdap Vaccines Regional Market Analysis
- 5.1 DTaP and Tdap Vaccines Production by Regions
- 5.1.1 Global DTaP and Tdap Vaccines Production by Regions
- 5.1.2 Global DTaP and Tdap Vaccines Revenue by Regions
- 5.2 DTaP and Tdap Vaccines Consumption by Regions
- 5.3 North America DTaP and Tdap Vaccines Market Analysis
- 5.3.1 North America DTaP and Tdap Vaccines Production
- 5.3.2 North America DTaP and Tdap Vaccines Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America DTaP and Tdap Vaccines Import and Export
- 5.4 Europe DTaP and Tdap Vaccines Market Analysis
- 5.4.1 Europe DTaP and Tdap Vaccines Production
- 5.4.2 Europe DTaP and Tdap Vaccines Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe DTaP and Tdap Vaccines Import and Export
- 5.5 China DTaP and Tdap Vaccines Market Analysis
- 5.5.1 China DTaP and Tdap Vaccines Production
- 5.5.2 China DTaP and Tdap Vaccines Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China DTaP and Tdap Vaccines Import and Export
- 5.6 Japan DTaP and Tdap Vaccines Market Analysis
- 5.6.1 Japan DTaP and Tdap Vaccines Production
- 5.6.2 Japan DTaP and Tdap Vaccines Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan DTaP and Tdap Vaccines Import and Export
- 5.7 Southeast Asia DTaP and Tdap Vaccines Market Analysis
- 5.7.1 Southeast Asia DTaP and Tdap Vaccines Production
- 5.7.2 Southeast Asia DTaP and Tdap Vaccines Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia DTaP and Tdap Vaccines Import and Export
- 5.8 India DTaP and Tdap Vaccines Market Analysis
- 5.8.1 India DTaP and Tdap Vaccines Production
- 5.8.2 India DTaP and Tdap Vaccines Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India DTaP and Tdap Vaccines Import and Export
6 DTaP and Tdap Vaccines Segment Market Analysis (by Type)
- 6.1 Global DTaP and Tdap Vaccines Production by Type
- 6.2 Global DTaP and Tdap Vaccines Revenue by Type
- 6.3 DTaP and Tdap Vaccines Price by Type
7 DTaP and Tdap Vaccines Segment Market Analysis (by Application)
- 7.1 Global DTaP and Tdap Vaccines Consumption by Application
- 7.2 Global DTaP and Tdap Vaccines Consumption Market Share by Application (2014-2019)
8 DTaP and Tdap Vaccines Major Manufacturers Analysis
- 8.1 Sanofi Pasteur
- 8.1.1 Sanofi Pasteur DTaP and Tdap Vaccines Production Sites and Area Served
- 8.1.2 Sanofi Pasteur Product Introduction, Application and Specification
- 8.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 GlaxoSmithKline
- 8.2.1 GlaxoSmithKline DTaP and Tdap Vaccines Production Sites and Area Served
- 8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Protein Sciences Corporation
- 8.3.1 Protein Sciences Corporation DTaP and Tdap Vaccines Production Sites and Area Served
- 8.3.2 Protein Sciences Corporation Product Introduction, Application and Specification
- 8.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Novartis AG
- 8.4.1 Novartis AG DTaP and Tdap Vaccines Production Sites and Area Served
- 8.4.2 Novartis AG Product Introduction, Application and Specification
- 8.4.3 Novartis AG DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Seqirus
- 8.5.1 Seqirus DTaP and Tdap Vaccines Production Sites and Area Served
- 8.5.2 Seqirus Product Introduction, Application and Specification
- 8.5.3 Seqirus DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Merck Sharp & Dohme Corp
- 8.6.1 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Production Sites and Area Served
- 8.6.2 Merck Sharp & Dohme Corp Product Introduction, Application and Specification
- 8.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Astellas Pharma US, Inc
- 8.7.1 Astellas Pharma US, Inc DTaP and Tdap Vaccines Production Sites and Area Served
- 8.7.2 Astellas Pharma US, Inc Product Introduction, Application and Specification
- 8.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Pfizer Inc
- 8.8.1 Pfizer Inc DTaP and Tdap Vaccines Production Sites and Area Served
- 8.8.2 Pfizer Inc Product Introduction, Application and Specification
- 8.8.3 Pfizer Inc DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Johnson & Johnson
- 8.9.1 Johnson & Johnson DTaP and Tdap Vaccines Production Sites and Area Served
- 8.9.2 Johnson & Johnson Product Introduction, Application and Specification
- 8.9.3 Johnson & Johnson DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Lanzhou Institute of Biological Products Co., Ltd
- 8.10.1 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Production Sites and Area Served
- 8.10.2 Lanzhou Institute of Biological Products Co., Ltd Product Introduction, Application and Specification
- 8.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 AstraZeneca
- 8.12 Emergent BioSolutions Inc
9 Development Trend of Analysis of DTaP and Tdap Vaccines Market
- 9.1 Global DTaP and Tdap Vaccines Market Trend Analysis
- 9.1.1 Global DTaP and Tdap Vaccines Market Size (Volume and Value) Forecast 2019-2025
- 9.2 DTaP and Tdap Vaccines Regional Market Trend
- 9.2.1 North America DTaP and Tdap Vaccines Forecast 2019-2025
- 9.2.2 Europe DTaP and Tdap Vaccines Forecast 2019-2025
- 9.2.3 China DTaP and Tdap Vaccines Forecast 2019-2025
- 9.2.4 Japan DTaP and Tdap Vaccines Forecast 2019-2025
- 9.2.5 Southeast Asia DTaP and Tdap Vaccines Forecast 2019-2025
- 9.2.6 India DTaP and Tdap Vaccines Forecast 2019-2025
- 9.3 DTaP and Tdap Vaccines Market Trend (Product Type)
- 9.4 DTaP and Tdap Vaccines Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 DTaP and Tdap Vaccines Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on DTaP and Tdap Vaccines. Industry analysis & Market Report on DTaP and Tdap Vaccines is a syndicated market report, published as Global DTaP and Tdap Vaccines Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of DTaP and Tdap Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
